Prosoma develops a clinically validated digital therapeutic platform, Living Well, that provides psychological and behavioral support specifically for cancer patients. This solution effectively reduces symptoms of stress, anxiety, and depression, enhancing patients' emotional well-being and overall quality of life during their treatment journey.
Funding
$16.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
IVVHFounders
Product
Problem
Cancer patients often experience significant stress, anxiety, and depression related to their diagnosis and treatment, which can negatively impact their emotional well-being and overall quality of life. Access to timely and effective psychological support is often limited, creating a gap in comprehensive cancer care.
Solution
Prosoma's Living Well platform is a clinically validated digital therapeutic that delivers psychological and behavioral support tailored to cancer patients. The platform aims to reduce symptoms of stress, anxiety, and depression through guided self-care modules. By providing accessible and reliable support, Living Well enhances patients' emotional functioning, improves their quality of life, and supports better overall outcomes during and after cancer treatment. The platform adheres to high standards of data security and quality management, aligning with HIPAA and FDA regulations in the US, MDR 2017/745 in Europe, and ISO 13485.
Target Audience
The primary target audience includes cancer patients seeking psychological and behavioral support, as well as healthcare professionals, healthcare providers, insurers, and pharmaceutical companies looking to integrate digital solutions into oncology care.
Features
- Clinically validated program designed specifically for cancer patients.
- Digital health care platform accessible via web and mobile devices.
- Self-care modules targeting stress, anxiety, and depression.
- Compliant with HIPAA, FDA, MDR 2017/745, ISO 13485, ISO/IEC 27001, and EU GDPR standards.
- Designed to align with the psycho-oncology standard of care for e-health in Germany (S3 Guideline).